|
Real-time Estimate
Cboe BZX
04:01:05 02/10/26 am AEST
|
5-day change | 1st Jan Change | ||
| 20.42 USD | -2.78% |
|
-8.93% | -34.19% |
| 14/08 | Oppenheimer Adjusts Pelthos Therapeutics PT to $64 From $66, Maintains Outperform Rating | MT |
| 13/08 | Pelthos Therapeutics Inc., Q2 2026 Earnings Call, Aug 13, 2026 |
Turnover - Evolution of Analysts' Estimates
Earnings Per Share (EPS) - Evolution of Analysts' Estimates
EBIT - Evolution of Analysts' Estimates
| 1m. Revenue rev. | 1y. Revenue rev. | 1y. EPS revision | ||
|---|---|---|---|---|
 | ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| Average | ||||
| Weighted average by Cap. |
Turnover
Earnings Per Share (EPS)
EBIT
- Stock Market
- Stocks
- PTHS Stock
- Consensus Pelthos Therapeutics Inc.
- Estimates Revisions
Select your edition
All financial news and data tailored to specific country editions
